The development of new antibiotics to treat the latest bacteria referred to as “super-bugs” is progressing slowly according to the latest report by the Infectious Disease Society of America (IDSA).This organization tracks the data from the rising number of antibiotic-resistant bacteria and the most affective medications. To learn more click here….